BCL2 and melanoma: In melanoma, the ratio of BAX, a pro-apoptotic protein, and Bcl-2, an anti-apoptotic protein, is considered to be important in relation to the susceptibility of melanoma to apoptosis [47]; thus, these proteins are considered as a therapeutic target [48,49].